4 курс / Акушерство и гинекология / Косова_А_С_Преэклампсия_современные_подходы_к_прогнозированию_и

121

hypertension / P.G. Teixeira, A. Cabral, S. Andrade et al. // Hypertension in pregnancy. – 2008. – Vol.27, N.1. – P. 65-73.

197.Thilaganathan, B. Early-pregnancy multiple serum markers and second-trimester uterine artery doppler in predicting preeclampsia / B. Thilaganathan, B. Wormald, C. Zanardini et al. // Obstet Gynecol. – 2010. – N.115. – P. 1233-1238.

198.Tidwell, S.C. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia / S.C. Tidwell, H.N. Ho, W.H. Chiu et al. // Am J Obstet Gynecol. – 2001. – N.184. – P. 1267-1272.

199.Tjwa, M. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis / M. Tjwa, A. Luttun, M. Autiero et al. // Cell Tissue Res. – 2003. – N.314. – P. 5-14.

200.Tobinaga, C.M. Angiogenetic factors and uterine Doppler velocimetry in earlyand late-oncet preeclampsia / C.M. Tobinaga, M.R. Torloni, B.Y. Gueuvoghlanian-Silva et al. // AOGS. – 2014. – Vol. 93, - N.5. – P. 469-476.

201.Tranquilli, A.L. Placental expression of nitric oxide synthase during HELLP syndrome / A.L. Tranquilli, S.R. Giannubilo, E. Tedeschi et al. // Acta Obstet Gynecol Scand. – 2005. – N.84. – P. 849-853.

202. Tranquilli, A.L. Preeclampsia: no longer solely a pragnansy disease / A.L. Tranquilli, B. Landi, S.R. Giannubilo, B. Sibai // Pregnancy Hypertens. – 2012. - Vol.2, N4. – P. 350 – 357.

203.Trivedi, N.A. A meta-analysis of low-dose aspirin for prevention of preeclampsia / N.A. Trivedi // J Postgrad Med Year. – 2011. – Vol.57, - N.2 – P. 91-95.

204.Tyler, C.P. Brain damage in preterm newborns and maternal medication: the Elgan Study / C.P. Tyler, N. Paneth, E.N. Allred et al. // Am J Obstet Gynecol. – 2012. – N.207. – P. 192e1 – 192e9.

205.Vatten, L.J. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia / L.J. Vatten, A. Eskild, T. Nilsen et al. // Am J Obstet Gynecol. – 2007. – Vol.196, N.3. – P. 239e1-239e6.

206.Venkat-Raman, N. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome / N. Venkat-Raman, T. May Backos,

122

W. Tech et al. // Obstet Gynecol. – 2001. – Vol.98, N.2. – P. 235-242.

207.Verloren, S. The sFlt-1/PIGF ratio in different types of hypertensive pregnancy

disorders and its prognostic potential in preeclamptic patients / S. Verloren, I. Herraiz, O. Lapaire // Am J Obstet Gynecol. – 2012. – Vol.206, N.1. – P. 58e1– 58e8.

208.Villa, P.M. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials / P.M. Villa, E. Kajantie, K. Räikkönen et al. // BJOG. – 2013. – Vol.120, - N.1. – P. 64–74.

209.Walker, J.J. Pre-eclampsia / J.J. Walker // Lancet. – 2000. – N.356. – P. 12601265.

210.Walsh, C.A. Mean arterial pressure and prediction of preeclampsia / C.A. Walsh,

L.V.Baxi // BMJ – 2008. – Vol.336, N.7653. – P. 1079-1080.

211. Wang, A. Preeclampsia: the role of angiogenic factors in its pathogenesis / A. Wang, S. Rana, S.A. Karumanchi // Physiology. – 2009. – Vol.24, N.3. – P. 147-158.

212.Wei, Shu-Qn. Maternal plasma 25-hydroxyvitamin D levels, angiogenic factors and preeclampsia / Shu-Qn Wei, F. Audibert Zong-Cheng Luo et al. // Am J Obstet Gynecol – 2013. – Vol.208, N.5. – P. 390e1 – 390e6.

213.Wen, Shi Wu. Folic acid supplementation in early second trimester and the risk of preeclampsia / Shi Wu Wen, Xi–Kuan Chen, M. Rodger et al. // Am J Obstet Gynecol. – 2008. – N.198. – P. 45e1-45e7.

214.Whitecar, P.W. Altered expression of TCR-CD3zeta induced by sera from women with preeclampsia / P.W. Whitecar, K.A. Boggess, M.J. McMahon et al. // Am J Obstet Gynecol. – 2001. – N.185. – P. 812 – 818.

215.Whitley, G.S. Trophoblast-mediated spiral artery remodelling: a role for apoptosis / G.S. Whitley, J.E. Cartwright // Anat. – 2009. – Vol.215, N.1. – P. 21-26.

216.WHO. Mother-Baby Pakage. Geneva, - 1994. – 85 p.

217.WHO. Reduction of maternal mortality. WHO, Geneva, - 2005. – 41 p.

218.WHO: Trends in maternal mortality: 1990 to 2013. Estimates by WHO, UNICEF,

123

UNFPA, The World Bank and the United Nations Population Division. WHO, - 2014. – 56 p.

219.Xu Xiong. Maternal smoking and preeclampsia / Xu Xiong, Fu-Lin Wang, S.T. Davidge // J Reprod Med. – 2000. – N.45. – P. 727-732.

220.Yamada, H. Anti-β2 glycoprotein-I antibody increases the risk of pregnancy-

induced hypertension: a case-controlled study / H. Yamada, T. Atsumi,

O.Amengual et al. // Journal of Reproductive Immunology. - 2010. – Vol.84, - N.1. - P. 95–99.

221.Yaron, Y. Decreased first trimester PAPP-A is a predictor of adverse outcome /

Y.Yaron, S. Heifetz, Y. Ochshorn et al. // Prenat Diagnos. – 2002. – Vol.22 – P.778–82.

222.Yu, J. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia / J. Yu, C.Z. Shixia, Y. Wu,

T.Duan et al. // Ultrasound Obstet Gynecol. – 2011. – Vol.37. – P. 528–533.

223.Yulug, E. Apoptotic and morphological features of the umbilical artery endothelium in mild and severe pre-eclampsia / E. Yulug, E. Yenilmez, M. Unsal et al. // Acta Obstet Gynecol Scand. – 2006. – Vol.85, N.9. – P. 1038-1045.

124